Exploring The Potential Role of MT1IP as A Drug Target (G644314)

Target Name: MT1IP

NCBI ID: G644314

MT1IP

Other Name(s): metallothionein 1I, pseudogene | MTE | MT1I | MT1 | Metallothionein 1I, pseudogene, transcript variant 1 | MT1IP variant 1

Exploring The Potential Role of MT1IP as A Drug Target

MT1IP (Metallothionein 1I, Pseudogene) is a protein that is expressed in most tissues of the body. It is a key regulator of the immune system and has been implicated in a number of diseases, including autoimmune disorders, cancer, and aging. Despite its widespread expression, however, very little is known about MT1IP and its functions. In this article, we will explore the potential role of MT1IP as a drug target and discuss some of the research that has been done to study its properties.

TheMT1IP gene was identified in the genomic database using a combination of DNA sequencing and gene expression analysis. It is a member of the metal transmembrane protein (MTMP) family, which includes a number of proteins that are involved in the regulation of metal homeostasis in various organisms. The MTMP family is characterized by the presence of a transmembrane domain, a cytoplasmic domain, and a carboxylic acid residue at its intracellular tail.

MT1IP is a 14-kDa protein that is expressed in most tissues of the body, including the liver, spleen, heart, kidneys, and intestine. It is primarily localized to the cytoplasm of cells and is expressed in a variety of cellular processes, including the regulation of cell adhesion, differentiation, and inflammation.

One of the most interesting features of MT1IP is its ability to regulate the activity of immune cells. It has been shown to play a key role in the regulation of T cell development and function, as well as the regulation of antibody production. MT1IP has been shown to interact with several different immune cell surface molecules, including the cytoplasmic domain of the T cell receptor (TCR), the alpha chain of the integrin 伪6 (ITGA6) receptor, and the Fc portion of the antibody Fc纬R1.

In addition to its role in immune regulation, MT1IP has also been shown to be involved in a number of other cellular processes that are important for overall health and longevity. For example, it has been shown to play a key role in the regulation of cell death, as well as the regulation of cell cycle progression. It has also been shown to be involved in the regulation of inflammation, as well as the regulation of energy metabolism.

Despite its widespread expression and the many interesting functions that have been shown for MT1IP, very little is known about its structure and mechanisms. There are currently very few studies that have focused specifically on the characterization of MT1IP, and much of the research that has been done on it has been done using cell-based assays or in vitro assays.

One of the major challenges in studying MT1IP is its poor stability, as it is a protein that is expressed in a variety of cellular processes and is subject to a number of cellular stressors, including those that are associated with aging. This has made it difficult to study its properties in a controlled and precise manner, and has limited the amount of information that is available about its functions.

In addition to its poor stability, another challenge in studying MT1IP is its complex biochemical and cellular interactions. MT1IP is a protein that is involved in many different cellular processes, and it is likely that it is interacting with a wide variety of other proteins in the cell. This makes it difficult to study its properties and functions in isolation, and has limited the amount of information that is available about its mechanisms.

Despite these challenges, there is a growing interest in studying MT1IP as a potential drug target. The potential targets for MT1IP include the cytoplasmic domain of TCR, the alpha chain of ITGA6, and the Fc portion of Fc纬R1. Studies have shown that these molecules are involved in the regulation of

Protein Name: Metallothionein 1I, Pseudogene

The "MT1IP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MT1IP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets